Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Формат: Artigo
Язык:Russo
Опубликовано: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Серии:Vestnik Transplantologii i Iskusstvennyh Organov
Предметы:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Online-ссылка:https://journal.transpl.ru/vtio/article/view/1194
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы